|
|
Year |
Title |
Citation |
Authors |
Review type |
Summary |
Keywords |
File filename |
File mime type |
1. |
|
2010 |
A 21-year-old man with Stillâs disease with fever, rash, and pancytopenia. |
Arthritis Care Res (Hoboken) 2010; 62:575-9. |
|
|
|
|
|
|
2. |
|
2010 |
Utility of leflunomide in the treatment of complex CMV syndromes |
Transplantation 2010 |
|
|
|
|
|
|
3. |
|
2010 |
Reply to Hage et al (letter). |
Clin Infect Dis 2010; 50:123-4 |
|
|
|
|
|
|
4. |
|
2010 |
infectious disease following kidney transplantation: Core Curriculum 2010 |
Am J Kidney Dis 2010; 55(4): 755-771 |
|
|
|
|
|
|
5. |
|
2010 |
Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients |
Transpl Infect Dis 2010 |
|
|
|
|
|
|
6. |
|
2010 |
Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation. A randomized, controlled trial |
Ann Intern Med 2010; 152:761-769. (note: Davis and Avery are co-senior authors). |
|
|
|
|
|
|
7. |
|
2010 |
Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group |
Transpl Infect Dis 2010; 12:190-194. |
|
|
|
|
|
|
8. |
|
2009 |
Strategies for safe living following solid organ transplantation. |
Am J Transplant 2009; 9 Suppl 4; S252-7. |
|
|
|
|
|
|
9. |
|
2009 |
Aspergillosis in hematopoietic stem cell transplant recipients: risk factors, prophylaxis, and treatment |
Curr Infect Dis Rep 2009 May; 11:223-8. |
|
|
|
|
|
|
10. |
|
2009 |
Screening of donor and recipient prior to solid organ transplantation |
Am J Transplant 2009; 9 Suppl 4: S7-18. |
|
|
|
|
|
|
11. |
|
2009 |
Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. |
Clin Infect Dis 2009; 49:710-6 |
|
|
|
|
|
|
12. |
|
2009 |
Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients |
Liver Transpl 2009; 15: 1557-63 |
|
|
|
|
|
|
13. |
|
2009 |
Near-total human face transplantation for a severely disfigured patient in the USA |
Lancet 2009 Jul 18; 374:203-9 |
|
|
|
|
|
|
14. |
|
2008 |
Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients |
Transpl Infect Dis 2008 Dec; 10:403-8 |
|
|
|
|
|
|
15. |
|
2008 |
Update in management of ganciclovir-resistant cytomegalovirus infection. |
Curr Opinion Infect Dis 2008; 21:433-7 |
|
|
|
|
|
|
16. |
|
2008 |
Update on immunizations in solid organ transplant recipients: what clinicians need to know |
American Journal of Transplantation 2008; 8:9-14. |
|
|
|
|
|
|
17. |
|
2008 |
Classic concepts and modern developments in transplant infectious disease: the work of Robert H. Rubin |
Curr Opin Organ Transplant 2008 (Dec): 13:601-3 |
|
|
|
|
|
|
18. |
|
2007 |
Valganciclovir vs. IV ganciclovir for therapy of cytomegalovirus viremia: has victory been achieved? |
American Journal of Transplantation 2007; 7: 2062-3. |
|
|
|
|
|
|
19. |
|
2007 |
Approach to the Immunocompromised Patient |
Hospital Medicine Secrets, ed. Glasheen JJ (assoc editor Amir Jaffer) Mosby/Elsevier 2007. Chapter 53, pp. 350-354. |
|
|
|
|
|
|
20. |
|
2007 |
Management of Fever and Neutropenia in Leukemia |
Clinical Malignant Hematology, eds. Sekeres MA, Kalaycio ME, Bolwell BJ, McGraw-Hill 2007. Chapter 34, pp 311-320 |
|
|
|
|
|
|
21. |
|
2007 |
Infections after kidney transplantation. |
Kidney Transplantation: State of the Art, second edition, ed Donald E. Hricik. Remedica 2007, London, UK and Chicago, US, pp 139-164 |
|
|
|
|
|
|
22. |
|
2007 |
Management of late, recurrent, and resistant cytomegalovirus in transplant patients |
Transplantation Reviews 2007; 21: 65-76 |
|
|
|
|
|
|
23. |
|
2007 |
Strategies for infection prevention after kidney transplantation. |
Current Opinion in Organ Transplantation 2007; 12:362-370. |
|
|
|
|
|
|
24. |
|
2007 |
Ganciclovir-resistant cytomegalovirus disease in heart transplant recipients: the dilemma of donor-positive/recipient-negative serostatus |
Clinical Infectious Diseases 2007; 45:448-9. |
|
|
|
|
|
|
25. |
|
2007 |
Second look at leflunomide âfailureâ to control cytomegalovirus infection in the setting of renal failure |
Transpl Infect Dis 2007; 9: 260, author reply 260-1. |
|
|
|
|
|
|
26. |
|
2007 |
Endobronchial fungal disease: an under-recognized entity |
Respiration 2007; 74:88-104 |
|
|
|
|
|
|
27. |
|
2007 |
Scedosporium apiospermum (Pseudallescheria boydii) infections in lung transplant recipients |
J Heart Lung Transplant 2007; 26:350-6 |
|
|
|
|
|
|
28. |
|
2006 |
Fluoroquinolone resistance in Ureaplasma parvum in the United States |
J Clin Microbiol (2006 Apr) 44(4):1590-1. |
|
|
|
|
|
|
29. |
|
2006 |
Can donors with prior hepatitis be safely used for heart transplantation? |
J Heart Lung Transplant 2006; 25:805-813 |
|
|
|
|
|
|
30. |
|
2006 |
The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation |
J Heart Lung Transplant 2006; 25:820-824. |
|
|
|
|
|
|
31. |
|
2006 |
A young man with a cough, an abnormal chest radiograph, and multiple skin lesions. |
Cleve Clin J Med (2006 Mar) 73(3):273-80 |
|
|
|
|
|
|
32. |
|
2006 |
Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy. |
J Heart Lung Transplant (2006 Mar) 25(3):294-7 |
|
|
|
|
|
|
33. |
|
2006 |
Infections after lung transplantation |
Lung Transplantation: Evolving Concepts and Controversies; Guest Editor, Scott M. Palmer. Semin Resp Crit Care Med 2006; 27:544-551. |
|
|
|
|
|
|
34. |
|
2005 |
BK virus and renal dysfunction: not limited to kidney transplantation? |
Clin Infect Dis (2005 Dec 15) 41(12):1726-7 |
|
|
|
|
|
|
35. |
|
2005 |
Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia |
Mayo Clin Proc (2005 Sep) 80(9):1215-6 |
|
|
|
|
|
|
36. |
|
2005 |
The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single-center study. |
J Heart Lung Transplant (2005 Nov) 24(11):1766-9 |
|
|
|
|
|
|
37. |
|
2005 |
Fatal West Nile Virus infection after rituximab/fludarabineâinduced remission for non-Hodgkin's lymphoma |
Clin Lymphoma Myeloma (2005 Nov) 6(3):248-50. |
|
|
|
|
|
|
38. |
|
2005 |
Use of anti-HCV-positive organs |
Am J Transplant 2005; 5:1579 |
|
|
|
|
|
|
39. |
|
2005 |
Commentary: relevance of waning measles immunity after HSCT |
Contagion 2005; 2:225-227 |
|
|
|
|
|
|
40. |
|
2005 |
Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course |
Bone Marrow Transplant 2005; 35:497-9 |
|
|
|
|
|
|
41. |
|
2005 |
Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients |
Am J Transplant 2005; 5:544-8 |
|
|
|
|
|
|
42. |
|
2005 |
Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection |
Bone Marrow Transplant 2005; 35:375-81 |
|
|
|
|
|
|
43. |
|
2004 |
Neuralgic amyotrophy precipitated by Epstein-Barr virus. |
Neurology 2004; 62:1234-5. |
|
|
|
|
|
|
44. |
|
2004 |
Encephalitis due to human herpesvirus-6 after cardiac transplant â a case report. |
Am J Transplant, 2004; 4:1200-3. |
|
|
|
|
|
|
45. |
|
2004 |
Adding Gram-positive prophylaxis to fluoroquinolone regimens reduces streptococcal bacteraemias, but prophylaxis remains controversial. |
Journal of Clinical Oncology 2003; 21: 4127-4137.) Cancer Treat Rev 2004; 30:385-8. |
|
|
|
|
|
|
46. |
|
2004 |
Prophylactic strategies before organ transplantation |
Curr Opinion Infect Dis 2004; 17:353-6. |
|
|
|
|
|
|
47. |
|
2004 |
Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. |
J Heart Lung Transplant 2004; 23: 277-83. |
|
|
|
|
|
|
48. |
|
2004 |
Correlation between blood and bronchoalveolar lavage CMV viral load with histology and CMV immunochemistry in lung transplant recipients |
J Clin Microbiol 2004; 42; 2168-72. |
|
|
|
|
|
|
49. |
|
2004 |
Guidelines for the Prevention and Management of Infectious Complications of Solid Organ Transplantation |
Am J Transplant 2004; Suppl 10: 5-166. |
|
|
|
|
|
|
50. |
|
2004 |
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection |
Bone Marrow Transplant 2004; 34:1071-5. |
|
|
|
|
|
|
51. |
|
2003 |
Cardiac-allograft vasculopathy |
N Engl J Med 2003; 349:829-30. |
|
|
|
|
|
|
52. |
|
2003 |
Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients:Â a case based review |
Transplant Infectious Disease 2003; 5:98-103 |
|
|
|
|
|
|
53. |
|
2003 |
Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi |
Clin Infect Dis 2003; 37:221-9 |
|
|
|
|
|
|
54. |
|
2003 |
Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant |
Infect Dis 2003; 36:1503-4, author reply 1504 |
|
|
|
|
|
|
55. |
|
2003 |
Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients |
Clin Infect Dis 2003; 36:46-52 |
|
|
|
|
|
|
56. |
|
2002 |
A case of zygomycosis and invasive candidiasis invloving the epiglottis and tongue in an immunocopromised patient. |
Scand J Infect Dis. 2002; 34 (2): 149-51 |
|
|
|
|
|
|
57. |
|
2002 |
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high dose etoposide (VP-16) for stem cell mobilization |
Bone Marrow Transplant 2002; 30: 311-4 |
|
|
|
|
|
|
58. |
|
2002 |
Recipient screening prior to solid-organ transplantation |
Clinical Infectious Diseases 2002; 35: 1513-9. |
|
|
|
|
|
|
59. |
|
2002 |
Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant receipients |
J Infect Dis 2002; 186: 760-8 |
|
|
|
|
|
|
60. |
|
2002 |
Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection |
Transpl Infect Dis 2002; 4:189-194. |
|
|
|
|
|
|
61. |
|
2002 |
Adult immunization and antibiotic prophylaxis guidelines |
Disease Management Project, 2002. |
|
|
|
|
|
|
62. |
|
2002 |
Transplant recipients and the threat of bioterrorism |
AST Newsletter 2002; 1(5): 1-3 |
|
|
|
|
|
|
63. |
|
2002 |
Pneumonia in the immunocompromised host |
Current Treatment Options in Infectious Disease 2002; 4(3): 249-266 |
|
|
|
|
|
|
64. |
|
2002 |
The relationship between cytomegalovirus and chronic allograft dysfunction. |
Transplantation Clinical Management Module Vol. 7, Medscape Transplantation |
|
|
|
|
|
|
65. |
|
2002 |
The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants |
Transpl Infect Dis 2002; 4:195-200. |
|
|
|
|
|
|
66. |
|
2001 |
Hepatitis A vaccine in liver transplant recipients |
Clin Infect Dis  2001; 32 (11): 1656-7 |
|
|
|
|
|
|
67. |
|
2001 |
Immigrant womenâs health: Infectious diseases - Part 2 |
West J Med 2001; 175:277-9 |
|
|
|
|
|
|
68. |
|
2001 |
Fungal infections in the organ transplant recipient |
Curr Opinion Organ Transplant 2001; 6:284-289. |
|
|
|
|
|
|
69. |
|
2001 |
Immunizations in adult immunocompromised patients: Which to use and which to avoid. |
Cleveland Clinic Journal of Medicine 2001; 68:337-48 |
|
|
|
|
|
|
70. |
|
2001 |
Hypogammaglobulinemia after heart transplantation: impact of preemptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes. |
Transplant Infectious Disease 2001; 3 Suppl 2:40-3. |
|
|
|
|
|
|
71. |
|
2001 |
Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation. |
Bone Marrow Transplant 2001 Sep; 28 (5): 491-5. |
|
|
|
|
|
|
72. |
|
2001 |
Viral triggers of cardiac-allograft dysfunction |
N Engl J Med 2001; 344 (20): 1545-7. |
|
|
|
|
|
|
73. |
|
2001 |
Prophylactic measures in the solid-organ recipient before transplantation |
Clinical Infectious Disease (2001 July 1) 33 Suppl 1: S15-21 |
|
|
|
|
|
|
74. |
|
2001 |
Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection. |
Journal Heart Lung Transplant  2001 20(4): 425-30 |
|
|
|
|
|
|
75. |
|
2001 |
Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies. |
Transplant Infectious Disease 2001; 3 (3): 161-7. |
|
|
|
|
|
|
76. |
|
2001 |
Immigrant womenâs health: Infectious diseases - Part 1. Clinical assessment, tuberculosis, hepatitis, and malaria |
West J Med 2001; 175:208-11 |
|
|
|
|
|
|
77. |
|
2000 |
The use of combination cytomegalovirus immune globulin (CMVIG) plus ganciclovir for prophylaxis in CMV seronegative liver transplant recipients of a CMV seropositive donor organ: a multicenter, open-label study |
Transplant Proc 2000; 33:2571-5. Â |
|
|
|
|
|
|
78. |
|
2000 |
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients |
Bone Marrow Transplantation 2000; 25:67-9 |
|
|
|
|
|
|
79. |
|
2000 |
Significant post-transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon? |
Transplant Infectious Disease 2000; 2:133-139. |
|
|
|
|
|
|
80. |
|
2000 |
A survey of CMV prophylaxis strategies among bone marrow transplant programs in the United States |
Bone Marrow Transplant 2000; 26:763-7 |
|
|
|
|
|
|
81. |
|
2000 |
Mycobacterium fortuitum osteomyelitis in a peripheral blood stem cell transplant recipient. |
Scand J Infect Dis 2000; 32:94-96 |
|
|
|
|
|
|
82. |
|
2000 |
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis |
Transplant Infectious Disease 2000; 3 (2) 112-117 |
|
|
|
|
|
|
83. |
|
1999 |
Special considerations regarding CMV in lung transplantation |
Transplant Infectious Disease 1999; Suppl, 1:13-18 |
|
|
|
|
|
|
84. |
|
1999 |
Isolated primary hepatic lymphoma in a patient with acquired immunodeficiency syndrome |
International Journal of Infectious Diseases, 1999 Vol 4 Number 1: 57-58. |
|
|
|
|
|
|
85. |
|
1999 |
Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? |
Clin Infect Dis 1999;28:240-246. |
|
|
|
|
|
|
86. |
|
1999 |
Immunogenicity of hepatitis A vaccine in decompensated liver disease |
Am J Gastroenterol 1999; 94:1601-4 |
|
|
|
|
|
|
87. |
|
1999 |
Solid organ transplant-related infectious disease for the home care clinician. |
Home Health Care Consultant 1999; 6:29-39 |
|
|
|
|
|
|
88. |
|
1999 |
Prevention of cytomegalovirus disease in allogeneic bone marrow transplant recipients |
Current Controversies in Bone Marrow Transplantation, ed. Brian Bolwell, Humana Press, |
|
|
|
|
|
|
89. |
|
1999 |
Evolving concepts in the management of patients with neutropenia and fever. |
Cleve Clin J Med 1999; 66:173-80. |
|
|
|
|
|
|
90. |
|
1999 |
Monitoring of CMV infection after renal transplantation: serology, culture, and viral DNA detection by hybrid capture |
Transplant Proc 1999; 31:1255-7 |
|
|
|
|
|
|
91. |
|
1999 |
Vaccination of the immunosuppressed adult patient with rheumatologic disease. |
General Medical Care of the Patient with Rheumatic Disease, eds. Brian Mandell and Michael J. Baime, Rheumatic Disease Clinics of North America, 1999, 25:567-584. |
|
|
|
|
|
|
92. |
|
1999 |
Listeria monocytogenes tricuspid valve endocarditis with septic pulmonary emboli in a liver transplant recipient |
Transplant Infectious Disease 1999 Dec;1(4):284-287 |
|
|
|
|
|
|
93. |
|
1998 |
Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients |
Clin Infect Dis 1998; 26:753-5 |
|
|
|
|
|
|
94. |
|
1998 |
Chlamydial disease |
Principles and Practice of Ophthalmology, Second Edition, Chapter 250, WB Saunders |
|
|
|
|
|
|
95. |
|
1998 |
Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipients |
Curr Opinion Cardiol 1998; 13;122-129 |
|
|
|
|
|
|
96. |
|
1998 |
Infectious disease and transplantation: messages for the generalist |
Cleve Clin J Med 1998; 65:305-14. |
|
|
|
|
|
|
97. |
|
1998 |
A randomized prospective controlled trial of oral acyclovir vs. oral ganciclovir for CMV prophylaxis in high risk kidney transplant recipients |
Transplantation 1998; 66:1682-8 |
|
|
|
|
|
|
98. |
|
1998 |
Routine cultures of bone marrow and peripheral stem cell harvests: clinical impact, cost analysis, and review |
Clin Infect Dis 1998; 28:240-6. |
|
|
|
|
|
|
99. |
|
1997 |
Significance of positive cultures from donor left atrium and postpreservation fluid in heart transplantation. |
Transplantation 1997; 64:1209-10 |
|
|
|
|
|
|
100. |
|
1997 |
Approach to the adult patient with recurrent infections |
Cleveland Clinic J Med 1997, 64(5):249-257. |
|
|
|
|
|
|
101. |
|
1997 |
Life after 20 years with a kidney transplant: redefined disease profiles and an emerging nondiabetic vasculopathy. |
Transplant Proc 1997;29:247-249 |
|
|
|
|
|
|
102. |
|
1996 |
Respiratory dimorphic fungal infections |
Topics in Clinical Dermatology, ed. Boni E. Elewski |
|
|
|
|
|
|
103. |
|
1996 |
Serous retinal   detachments in a patient with clinically resistant cytomegalovirus retinitis |
Archives  of Opthalmology. 1996 July;114(7):896-897. |
|
|
|
|
|
|
104. |
|
1996 |
The spectrum of orbital   aspergillosis. |
Survey of Ophthalmology, 1996, 41:142-54 |
|
|
|
|
|
|
105. |
|
1996 |
Cytomegalovirus infection in seromismatched lung transplant  recipients with and without prophylaxis with CMV immunoglobulin |
Transplant Proc 1996 Dec;28(6 Suppl 2):16. |
|
|
|
|
|
|
106. |
|
1996 |
Bilateral otitis media and  mastoiditis caused by a highly resistant strain of Mycobacterium chelonae |
Pediatric Infectious Disease Journal 1996 Nov;15(11):1037-1040 |
|
|
|
|
|
|
107. |
|
1995 |
Transmission of Toxoplasma gondii infection by liver transplantation. |
Clin Infect Dis 21:511-5, 1995 |
|
|
|
|
|
|
108. |
|
1995 |
Inhibition  of cytotoxic T lymphocyte-triggered apoptosis by target cell surface-coupled  aprotinin |
Mol Immunol 1995, 32(12):853-864 |
|
|
|
|
|
|
109. |
|
1995 |
Viral pulmonary infections in thoracic and cardiovascular surgery. |
Semin Thorac Cardiovasc Surg 1995;7:88-94 |
|
|
|
|
|
|
110. |
|
1995 |
Rhinoscleroma treated with ciprofloxacin: a case report. |
The Laryngoscope, 105:1-3, July 1995 |
|
|
|
|
|
|
111. |
|
1994 |
Infections and immunizations in organ transplant recipients: a preventive approach. |
Cleveland Clinic J Med 1994;61(5):386-392 |
|
|
|
|
|
|
112. |
|
1994 |
Chlamydial infection |
Principles and Practice of Ophthalmology, eds. Daniel M. Albert and Frederick A. Jakobiec, W.B. Saunders |
|
|
|
|
|
|
113. |
|
1994 |
Mycoplasma hominis wound infection |
Infect Dis Clin Pract,1994;3(1):32-34 |
|
|
|
|
|
|
114. |
|
1992 |
Human Immunodeficiency Virus and Homeless Persons. |
Delivering Health Care to Homeless Persons, eds. David Wood |
|
|
|
|
|
|
115. |
|
1992 |
Differences between ATP-mediated cytotoxicity and cell-mediated cytotoxicity |
J Immunol, August, 1992 |
|
|
|
|
|
|
116. |
|
1991 |
AIDS and HIV Infection |
The Manual of Common Communicable Diseases in Shelters, eds. James J. O'Connell and Janet Groth, Boston Health Care for the Homeless Program |
|
|
|
|
|
|
117. |
|
1990 |
Homelessness and AIDS |
Under the Safety Net:Â The Health and Social Welfare of the Homeless in the United States, eds. P.W. Brickner et al, W.W. Norton, New York/London |
|
|
|
|
|
|